Table 3.
Mendelian randomization analysis results of causal CpG sites for metabolic traits, selected among the top ten EWAS most significant hits
Exposure | MR resultsa | EWAS resultsb | CHR | CpG position in Genome Build 37 | Reference genec | Location of CpG related to genec | Relation to CpG Islandd | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | N SNPs | Beta | SE | p-value | CpG data | Beta | SE | p-value | ||||||
cg11622362 | Glucose | 2 | 0.019 | 0.005 | 0.0001 | T0 | − 1.05 | 0.22 | 2.96 × 10–5 | 11 | 34,938,112 | APIP* | TSS200 | Island |
cg09137125 | Glucose | 2 | − 0.003 | 0.007 | 0.63 | T0 | − 0.93 | 0.19 | 3.51 × 10–5 | 10 | 7,486,981 | |||
cg26295559 | Glucose | 4 | 0.003 | 0.004 | 0.55 | T0-T1 | − 2.40 | 0.46 | 1.02 × 10–5 | 7 | 158,550,318 | ESYT2 | Body | |
cg09694300 | HDL | 2 | − 0.025 | 0.019 | 0.18 | T0 | − 1.25 | 0.28 | 5.58 × 10–5 | 3 | 159,429,667 | SCHIP1 | Body | |
cg23700124 | LDL | 2 | 0.001 | 0.005 | 0.86 | T0 | − 0.69 | 0.14 | 1.15 × 10–5 | 4 | 123,843,736 | SPATA5* | TSS1500 | Island |
cg03803210 | TG | 3 | 0.001 | 0.005 | 0.87 | T0-T1 | 1.93 | 0.34 | 8.93 × 10–7 | 8 | 17,438,816 | PDGFRL | Body | S_Shelf |
cg08387293 | TG | 2 | 0.002 | 0.008 | 0.82 | T0-T1 | − 3.22 | 0.58 | 1.13 × 10–6 | 1 | 984,383 | AGRN | Body | Island |
CHR chromosome, EWAS epigenome-wide association study, HDL high density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, MR Mendelian randomization, SE standard error, SNPs single nucleotide polymorphisms, TG triglycerides
aTwo-sample MR analyses using the inverse-variance weighted method were performed. Summary statistics for instrument-exposure association (n = 3,841) were retrieved from Bonder et al. [40], while instrument-outcome association statistics were derived from GWAS performed in the UKBiobank (http://www.nealelab.is/uk-biobank; n = 314′916 for glucose, n = 315′133 for HDL, n = 343′621 for LDL, n = 343,992 for TG). Significant p-values (< 0.05) are indicated in bold
bThe results of the EWAS using methylation M-values are displayed. For the first line, the magnitude of the effect in β-value is to be interpreted as follows: a difference of 1.4% in baseline methylation level (corresponding to baseline methylation IQR in PsyMetab sample) is associated with a 0.39 mM (SE = 0.07) smaller glucose increase. No result reached statistical significance
cReference genes for the methylation sites, and gene regions where the CpGs are located according to the UCSC database. Empty fields indicate an intergenic location
*Specifies there exists > 1 gene or gene transcript at this location. TSS200 = 0–200 bases upstream of the transcriptional start site (TSS); TSS1500 = 200–1500 bases upstream of the TSS; Body = between the ATG and stop codon, irrespective of the presence of introns, exons, TSS, or promoters
dThe relation to a putative nearby CpG island, according to the UCSC database, is given. S_Shelf = 2–4 kb downstream (3′) of CpG island